バイオバンク市場：構成要素、サンプルタイプ、用途別-2025-2030年の世界予測

バイオバンク市場は、2023年に678億1,000万米ドルと評価され、2024年には757億5,000万米ドルに達すると予測され、CAGR 11.80%で成長し、2030年には1,481億米ドルになると予測されています。

バイオバンクは、血液、細胞、組織、DNAなどの生物学的サンプルを収集・保存する重要な保管庫であり、主に研究や医学の進歩のために使用されます。その必要性は、個別化医療やゲノム研究に対する需要の高まりによって強調されており、病気の進行、薬剤開発、バイオマーカー探索の研究に重要なデータを提供するためです。バイオバンクの用途は、学術研究機関、製薬会社、病院と多岐にわたり、最終用途は個別化ヘルスケア、がん研究、再生医療に広がっています。バイオバンクの市場は、ゲノム技術の進歩、バイオバンキングプロジェクトに対する政府の資金援助、バイオ製薬企業による創薬イニシアティブへの投資の増加といった要因の影響を受けています。最新の潜在的なビジネスチャンスは、データ管理とセキュリティのための人工知能やブロックチェーンのようなデジタル技術の統合にあります。課題としては、データプライバシーに関する倫理的な懸念、バイオバンク管理に関連する高コスト、市場成長を阻害する規制の複雑さなどが挙げられます。また、サンプルの保管品質やバイオバンク施設間の標準化にも懸念があります。このような課題を克服するためには、凍結保存技術を改善し、サンプル収集と保存の標準化プロトコルを開発し、高品質で再現可能なサンプルデータを確保することに技術革新を向けることができます。さらに、KEYWORD間の共同ネットワークは、リソースや知識の共有を促進し、研究開発の進歩を促進することができます。市場は高い競争と急速な技術進化を特徴としており、最先端の能力を維持するために研究開発への継続的な投資が必要です。全体として、バイオバンク市場は技術統合と個別化医療の重視の高まりによって大きな成長の可能性を秘めており、戦略的提携とデータセキュリティの強化が成功の鍵を握っています。

市場力学：急速に進化するバイオバンク市場の主要市場インサイトを公開

バイオバンク市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の罹患率の増加
  • バイオバンクに関する意識の高まり
  • 大規模な老年人口基盤の存在と相まっての人口増加
• 市場抑制要因
  • バイオバンキングに関する倫理的・法的問題
• 市場機会
  • 各国におけるゲノム研究活動の活発化
  • ゲノム検査や幹細胞治療に対する一般市民の意識の高まり
• 市場の課題
  • バイオバンクの長期的持続可能性

ポーターの5つの力：バイオバンク市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、バイオバンク市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオバンク市場における外部からの影響の把握

外部マクロ環境要因は、バイオバンク市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析バイオバンク市場における競合情勢の把握

バイオバンク市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスバイオバンク市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオバンク市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨バイオバンク市場における成功への道筋を描く

バイオバンク市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の発症率の増加
    • バイオバンクに関する認知度の高まり
    • 人口増加と大規模な高齢者人口基盤の存在
  • 抑制要因
    • バイオバンキングに関連する倫理的および法的問題
  • 機会
    • 経済におけるゲノム調査活動の拡大
    • ゲノム検査と幹細胞治療に関する国民の意識向上
  • 課題
    • バイオバンクの長期的持続可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 バイオバンク市場：コンポーネント別

• 消耗品
• 装置
• サービス
• ソフトウェア

第7章 バイオバンク市場サンプルタイプ別

• 体液
• 血液製品
• 細胞株
• 人間の組織
• 核酸

第8章 バイオバンク市場：用途別

• 臨床調査
• ライフサイエンス調査
• 再生医療

第9章 南北アメリカのバイオバンク市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のバイオバンク市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのバイオバンク市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Acorn Biolabs, Inc.
• Artizan Biosciences, Inc.
• Bay Biosciences LLC
• Beckman Coulter, Inc. by Danaher Corporation
• Becton, Dickinson and Company
• BioLife Solutions Inc.
• LVL Technologies GmbH & Co. KG
• Merck KGaA
• ProteoGenex, Inc.
• Provia Laboratories, LLC
• Shanghai Zhangjiang Biobank
• Taylor-Wharton
• Tecan Trading AG
• Thermo Fisher Scientific Inc.
• UK Biobank Limited

LIST OF FIGURES

• FIGURE 1. BIOBANKS MARKET RESEARCH PROCESS
• FIGURE 2. BIOBANKS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOBANKS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BIOBANKS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BIOBANKS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOBANKS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOBANKS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOBANKS MARKET DYNAMICS
• TABLE 7. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOBANKS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOBANKS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOBANKS MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOBANKS MARKET SIZE, BY BLOOD PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOBANKS MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOBANKS MARKET SIZE, BY HUMAN TISSUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOBANKS MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOBANKS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIOBANKS MARKET SIZE, BY LIFE SCIENCE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOBANKS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 33. CANADA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CANADA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CHINA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 50. CHINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 51. CHINA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 53. INDIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ITALY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 105. ITALY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 106. ITALY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. POLAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 117. POLAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 118. POLAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. QATAR BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 120. QATAR BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 121. QATAR BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. BIOBANKS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 150. BIOBANKS MARKET, FPNV POSITIONING MATRIX, 2023

The Biobanks Market was valued at USD 67.81 billion in 2023, expected to reach USD 75.75 billion in 2024, and is projected to grow at a CAGR of 11.80%, to USD 148.10 billion by 2030.

Biobanks are crucial repositories that collect and store biological samples such as blood, cells, tissues, and DNA, predominantly for research and medical advancements. Their necessity is underscored by the increasing demand for personalized medicine and genomic research, as they provide critical data for studies on disease progression, drug development, and biomarker discovery. The application of biobanks spans across academic research institutions, pharmaceutical companies, and hospital settings, with a growing end-use scope in personalized healthcare, cancer research, and regenerative medicine. The market for biobanks is influenced by factors such as advances in genomic technologies, government funding for biobanking projects, and growing investments by biopharma companies in drug discovery initiatives. The latest potential opportunities lie in the integration of digital technologies like artificial intelligence and blockchain for data management and security-allowing more efficient sample tracking and usage, which can significantly enhance research outputs. Challenges include ethical concerns over data privacy, high costs associated with biobank management, and regulatory complexities which can impede market growth. There are also concerns over sample storage quality and standardization across biobanking facilities. To overcome these challenges, innovation can be directed towards improving cryopreservation techniques and developing standardized protocols for sample collection and storage to ensure high-quality and reproducible sample data. Additionally, collaborative networks among biobanks can facilitate the sharing of resources and knowledge, fostering advancements in research and development. The market is characterized by high competition and rapid technological evolution, necessitating continuous investment in R&D to maintain cutting-edge capabilities. Overall, the biobank market holds significant potential for growth driven by technological integration and a growing emphasis on personalized medicine, with strategic collaborations and enhanced data security being pivotal for success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biobanks Market

The Biobanks Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in incidence of chronic disease
  • Rising awareness about biobanks
  • Increasing population coupled with presence of a large geriatric population base
• Market Restraints
  • Ethical and legal issues related to biobanking
• Market Opportunities
  • Growing genomic research activities in economies
  • Increasing public awareness about genomic testing and stem cell therapies
• Market Challenges
  • Long-Term Sustainability of Biobanks

Porter's Five Forces: A Strategic Tool for Navigating the Biobanks Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biobanks Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biobanks Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biobanks Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biobanks Market

A detailed market share analysis in the Biobanks Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biobanks Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biobanks Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biobanks Market

A strategic analysis of the Biobanks Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biobanks Market, highlighting leading vendors and their innovative profiles. These include Acorn Biolabs, Inc., Artizan Biosciences, Inc., Bay Biosciences LLC, Beckman Coulter, Inc. by Danaher Corporation, Becton, Dickinson and Company, BioLife Solutions Inc., LVL Technologies GmbH & Co. KG, Merck KGaA, ProteoGenex, Inc., Provia Laboratories, LLC, Shanghai Zhangjiang Biobank, Taylor-Wharton, Tecan Trading AG, Thermo Fisher Scientific Inc., and UK Biobank Limited.

Market Segmentation & Coverage

This research report categorizes the Biobanks Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Component, market is studied across Consumables, Equipment, Services, and Software.
• Based on Sample Type, market is studied across Biological Fluids, Blood Products, Cell Lines, Human Tissues, and Nucleic Acids.
• Based on Application, market is studied across Clinical Research, Life Science Research, and Regenerative Medicine.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in incidence of chronic disease
    • 5.1.1.2. Rising awareness about biobanks
    • 5.1.1.3. Increasing population coupled with presence of a large geriatric population base
  • 5.1.2. Restraints
    • 5.1.2.1. Ethical and legal issues related to biobanking
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing genomic research activities in economies
    • 5.1.3.2. Increasing public awareness about genomic testing and stem cell therapies
  • 5.1.4. Challenges
    • 5.1.4.1. Long-Term Sustainability of Biobanks
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biobanks Market, by Component

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Equipment
• 6.4. Services
• 6.5. Software

7. Biobanks Market, by Sample Type

• 7.1. Introduction
• 7.2. Biological Fluids
• 7.3. Blood Products
• 7.4. Cell Lines
• 7.5. Human Tissues
• 7.6. Nucleic Acids

8. Biobanks Market, by Application

• 8.1. Introduction
• 8.2. Clinical Research
• 8.3. Life Science Research
• 8.4. Regenerative Medicine

9. Americas Biobanks Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Biobanks Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Biobanks Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Acorn Biolabs, Inc.
• 2. Artizan Biosciences, Inc.
• 3. Bay Biosciences LLC
• 4. Beckman Coulter, Inc. by Danaher Corporation
• 5. Becton, Dickinson and Company
• 6. BioLife Solutions Inc.
• 7. LVL Technologies GmbH & Co. KG
• 8. Merck KGaA
• 9. ProteoGenex, Inc.
• 10. Provia Laboratories, LLC
• 11. Shanghai Zhangjiang Biobank
• 12. Taylor-Wharton
• 13. Tecan Trading AG
• 14. Thermo Fisher Scientific Inc.
• 15. UK Biobank Limited